Better Buy: Eli Lilly vs. AbbVie

Neither Eli Lilly (NYSE: LLY) nor AbbVie (NYSE: ABBV) has provided much for investors to get excited about so far in 2019. Both big pharma stocks are down by single-digit percentages year to date. But Lilly and AbbVie each hold the potential to deliver more attractive returns down the stretch.

Which of these two stocks is the better pick for long-term investors? Here's how Lilly and AbbVie compare in several key areas.

Image source: Getty Images.

Continue reading

Source Fool.com